Table 2. Drug-related AEs occurring in ≥5% of patients (and all grade 3/4 AEs).
| AEa n [%] | Gefitinib related |
Celecoxib related |
|||
|---|---|---|---|---|---|
| Grade 1/2 | Grade 3/4 | Grade 1/2 | Grade 3/4 | ||
| Acne | 11 [37] | 1 [3] | 1 [3] | 0 [0] | |
| Diarrhea | 10 [33] | 1 [3] | 3 [10] | 0 [0] | |
| Stomatitis | 4 [13] | 0 [0] | 4 [13] | 0 [0] | |
| Skin desquamation | 4 [13] | 0 [0] | 2 [7] | 0 [0] | |
| Nausea | 3 [10] | 0 [0] | 4 [13] | 0 [0] | |
| Rash | 2 [7] | 0 [0] | 0 [0] | 0 [0] | |
| Pruritus | 2 [7] | 0 [0] | 0 [0] | 0 [0] | |
| Abdominal pain | 1 [3] | 0 [0] | 2 [7] | 0 [0] | |
| Vomiting | 1 [3] | 0 [0] | 2 [7] | 0 [0] | |
| Hypotension | 0 [0] | 1 [3] | 0 [0] | 0 [0] | |
| Upper abdominal pain | 0 [0] | 0 [0] | 3 [10] | 0 [0] | |
| Hepatitis | 0 [0] | 0 [0] | 0 [0] | 1 [3] | |
| Folliculitis | 0 [0] | 1 [3] | 0 [0] | 0 [0] | |
aA patient could have ≥1 AE. AE, adverse event.